StemCell Institute Inc.
株式会社ステムセル研究所
Valuation
Fundamental ratios for the latest reported period.
Ticker: 7096
FY2025 · 2026-03-31
| Gross margin | 60.9% |
| Operating margin | 7.2% |
| Net margin | 5.5% |
| Return on equity | 5.8% |
| Return on assets | 1.9% |
| Revenue growth (YoY) | — |
| EPS (basic) | ¥15.44 |
| EPS growth (YoY) | — |
| Current ratio | 1.17x |
| Equity ratio | 33.2% |
| Book value / share | ¥266.34 |
| Free cash flow | -336 M |